Clinical trial
Treatment of Sexual Dysfunction in Hypogonadal Men With Epilepsy With…
NCT00179517 · Beth Israel Deaconess Medical Center, Other · Completed
Key facts
| NCT number | NCT00179517 |
|---|---|
| Title | Treatment of Sexual Dysfunction in Hypogonadal Men With Epilepsy With Testosterone and Either Anastrozole or Placebo |
| Official title | Comparison of Anastrozole and Testosterone Versus Placebo and Testosterone Treatment of Reproductive and Sexual Dysfunction in Men With Epilepsy and Hypogonadism |
| Lead sponsor | Beth Israel Deaconess Medical Center, Other |
| Collaborators | AstraZeneca Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Seizure Disorder, Hypogonadism, Erectile Dysfunction |
| Intervention type | Drug |
| Interventions | Anastrozole 1mg, Placebo Oral Tablet |
| Enrollment | 40 |
| Start date | Jun 1, 2001 |
| Primary completion | Apr 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | Sep 16, 2005 |
| Last update posted | Jul 17, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: